AbbVie Share Holder Equity 2010-2024 | ABBV

AbbVie share holder equity for the quarter ending December 31, 2024 was $3.364B, a 67.64% decline year-over-year.

  • AbbVie share holder equity for 2024 was $3.364B, a 67.64% decline from 2023.
  • AbbVie share holder equity for 2023 was $10.397B, a 39.86% decline from 2022.
  • AbbVie share holder equity for 2022 was $17.287B, a 11.99% increase from 2021.

AbbVie Share Holder Equity 2010-2024 | ABBV

  • AbbVie share holder equity for 2024 was $3.364B, a 67.64% decline from 2023.
  • AbbVie share holder equity for 2023 was $10.397B, a 39.86% decline from 2022.
  • AbbVie share holder equity for 2022 was $17.287B, a 11.99% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B